德克萨斯大学 MD 安德森癌症中心博士后职位–实验放射肿瘤学系方向
Postdoctoral positions are immediately available to work in the area of immune checkpoint receptor signaling and cancer biology in Dr. Marian Kalocsay’s laboratory. The lab focuses on mass spectrometry and receptor signaling pathways involved in tumor initiation, progression, and metastasis. Our approaches range from TMT multiplexed quantitative proteomics, mammalian cell culture, molecular biology, and biochemistry to mouse genetics. We also conduct large-scale proteomic studies screens to explore various cancer-related signal transduction pathways.
The individual is expected to learn independent management and execution of defined research projects in cancer biology. For this, mass spectrometry analysis of biological samples employing tandem mass tag (TMT) analysis with orbitrap instruments (TMT-MS) is required, which involves sample preparation, instrument operation, development of MS workflows, and data analysis. All of these will be learned during the course of studies.
An individual holding a recent Ph.D. or equivalent doctorate is seeking a temporary appointment, under the supervision of a faculty mentor, involving full-time laboratory-based research or scholarship in preparation for an academic or research career as an independent investigator.
ADDITIONAL APPLICATION INFORMATION
We seek applicants who are self-motivated and career-oriented to join an exciting and highly interactive research team. We have a track record of training the best and the brightest postdoctoral fellows who become independent group leaders in the United States and other countries. The research environment at MD Anderson is outstanding and nurturing, especially for applicants who are interested in cancer biology and translational collaborations.
It is the policy of The University of Texas MD Anderson Cancer Center to provide equal employment opportunity without regard to race, color, religion, age, national origin, sex, gender, sexual orientation, gender identity/expression, disability, protected veteran status, genetic information, or any other basis protected by institutional policy or by federal, state or local laws unless such distinction is required by law. http://www.mdanderson.org/about-us/legal-and-policy/legal-statements/eeo-affirmative-action.html